March 21 (Reuters) - Raptor Pharmaceutical Corp RPTP.O
* Health canada accepted for review its new drug submission
for procysbi delayed-release capsules with priority review
status
Source text for Eikon: ID:nGNXMQELBa
Further company coverage: RPTP.O
(Bengaluru Newsroom: +1-646-223-8780)